How could it be that the most powerful and richest nation in the world, the United States is discussing about the same failures of the health care system for decades? How a good health care system might look like and what challenges are to be overcome are additional questions this paper seeks to answer.
This paper asks why the US has still not achieved a high quality medical service standard at low costs reaching all citizens, even though there were several attempts for a major structural reform over the last decades.
The hypothesis guiding this paper is therefore that due to power structures and lobbying the U.S. health system has low efficacy (coverage of all citizens in a fair way) and low efficiency (the relation between costs and outcome).
To answer this question one has to put it into context. Since there is an ongoing discussion with ups and downs for more than 70 years the question that comes up first is, how this peculiarity of the US case is possible? What might be the path-dependency that explains why: “The United States is the only western industrialized nation that fails to provide universal coverage and the only nation where health care for the majority of the population is financed by for-profit, minimally regulated private insurance companies.”(Quadango ) This paper argues that the failures of the U.S. health care system, being debated continuously over decades can’t be explained just by referring to “American Exceptionalism”, a culture and history that favours free market regulation. Though this and other popular explanations might play a role, this paper argues that power structures in U.S. society and specifically in the health care sector better explain the current system.
Table of Contents
1. Introduction
2. Background
2.1. An old agenda: National Health Insurance
2.2. What makes a good health system?
3. The current Situation
3.1. The best or just the most expensive system?
3.2. A cross- country Comparison
4. The policy-planning network: Power Structures in the US Health Sector
4.1. Myths of the US health sector
4.1.1. American Exceptionalism -The people want it this way?
4.1.2. Isn’t everything getting more expensive?
4.2. Channels of Influence. Big Pharma in Washington
5. Conclusion
Objectives & Core Topics
This paper examines why the United States, despite being a wealthy and technologically advanced nation, lacks a universal health care system. The study challenges the notion of "American Exceptionalism" as the primary driver for this state of affairs and instead argues that entrenched power structures, specifically the lobbying influence of well-organized interest groups like the American Medical Association and the pharmaceutical industry, are responsible for maintaining an inefficient and inequitable health system that serves private interests over public health needs.
- The historical development and persistent failure of universal health care initiatives in the U.S.
- An evaluation of U.S. health care performance based on WHO quality indicators.
- The role of "policy-planning networks" and strategic alliances in shaping health legislation.
- Critical analysis of myths surrounding health care costs and technological progress.
- The impact of lobbying and political campaign contributions on health care policy outcomes.
Book Excerpt
1. Introduction
“The problem of providing satisfactory medical services to all the people of the United States at costs which they can meet is a pressing one. At the present time many persons do not receive service that is adequate either in quantity or quality and the costs of service are inequitably distributed. The result is a tremendous amount of preventable physical pain and mental anguish, needless deaths, economic inefficiency, and social waste. Furthermore, these are largely unnecessary. The United States has the economic resources and organizing ability and the technical experience to solve this problem.“
This was the diagnosis of the U.S. Committee on the Costs of Medical Care, written in 1932. One might think it was written today and indeed there are many very similar voices in the current health care debate. How could it be that the most powerful and richest nation in the world, the United States is still discussing about the same issues in health care? The statement is also powerful because it indirectly defines how a good health care system might look like and what challenges have to be overcome. There are the following three main criteria. A satisfactory medical service points at higher quality standards, at low costs and thirdly reaching all citizens. This paper asks why the U.S. has still not achieved these three major goals.
The hypothesis guiding the more descriptive first part of this paper is therefore that the U.S. health system has low efficacy (coverage of all citizens in a fair way) and low efficiency (the relation between costs and outcome).
Summary of Chapters
1. Introduction: Outlines the persistence of health care inequality in the U.S. since 1932 and proposes the hypothesis that current power structures, rather than culture, hinder reform.
2. Background: Reviews historical attempts at implementing national health insurance and defines the criteria for a good health system.
3. The current Situation: Demonstrates that the U.S. health system is comparatively the most expensive while scoring low on efficiency and fairness benchmarks.
4. The policy-planning network: Power Structures in the US Health Sector: Analyzes how organized interest groups and the pharmaceutical lobby exert influence over public policy to protect their economic interests.
5. Conclusion: Summarizes that true health care reform is hindered by organized opposing interests and suggests that grassroots advocacy remains essential for future change.
Keywords
U.S. health system, national health insurance, American Exceptionalism, health care policy, power structures, lobbying, pharmaceutical industry, American Medical Association, universal coverage, health care inequality, health care costs, political influence, health care reform, market failure.
Frequently Asked Questions
What is the core argument of this work?
The paper argues that the failures of the U.S. health care system are not merely due to cultural attitudes like "American Exceptionalism," but are the result of powerful, well-organized interest groups that systematically influence policy to favor their economic interests over universal access.
What are the primary themes analyzed in the paper?
The core themes include the historical failure of universal health care, comparative analysis of health system efficiency, the role of lobbying by the pharmaceutical sector, and the disparity between public opinion and policy outcomes.
What is the ultimate goal of the research?
The goal is to provide a structural explanation for why the United States, as a wealthy nation, has failed to achieve high-quality, universal health care coverage, and to identify the actors responsible for this outcome.
Which scientific methodology is applied?
The study uses an empirical, comparative approach, incorporating WHO standards and macro-economic data, combined with a political-sociological analysis of power structures and institutional lobbying.
What does the main body of the work cover?
It covers the historical background of health care debates, an empirical evaluation of the current U.S. system compared to other OECD nations, and an explanatory model detailing how lobbying and "policy-planning networks" shape the legislative environment.
Which keywords best describe this study?
The most relevant keywords include: U.S. health system, power structures, lobbying, health care inequality, and universal coverage.
How does the author define a "good" health system?
The author uses three WHO criteria: good health for the entire population, responsiveness to patient expectations, and fairness in financing based on ability to pay.
What role does the pharmaceutical industry play in the author's model?
The industry is described as a central part of a "policy-planning network" that uses massive financial resources, extensive lobbying, and the "revolving door" between government and private industry to prevent cost controls and protect profits.
- Citation du texte
- Malko Ebers (Auteur), 2005, Everything but healthy - A power structure analysis of the U.S. health system, Munich, GRIN Verlag, https://www.grin.com/document/52634
